{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:33:11Z","timestamp":1788049991878,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K11467"],"award-info":[{"award-number":["JP24K11467"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K07779"],"award-info":[{"award-number":["JP23K07779"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012069","name":"Hoyu Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jid.2025.06.1596","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:48:05Z","timestamp":1753141685000},"page":"374-382.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-3233","authenticated-orcid":false,"given":"Ken","family":"Okamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5143-4661","authenticated-orcid":false,"given":"Yosuke","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1054-9072","authenticated-orcid":false,"given":"Junnosuke","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5427-7665","authenticated-orcid":false,"given":"Shinji","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8333-1507","authenticated-orcid":false,"given":"Aki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0903-873X","authenticated-orcid":false,"given":"Yuko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8847-0063","authenticated-orcid":false,"given":"Keitaro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-6430","authenticated-orcid":false,"given":"John E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4669-9721","authenticated-orcid":false,"given":"Tamio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.06.1596_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/1346-8138.15534","article-title":"Expression of discoidin domain receptor 1 and E-cadherin in epidermis affects melanocyte behavior in rhododendrol-induced leukoderma mouse model","volume":"47","author":"Abe","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jdermsci.2022.04.005","article-title":"The effect of a topical vitamin D3 analog on repigmentation in mice with rhododendrol-induced leukoderma","volume":"106","author":"Abe","year":"2022","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.06.1596_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdermsci.2015.10.011","article-title":"Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin","volume":"81","author":"Abe","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.06.1596_bib4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/jid.2014.529","article-title":"Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo","volume":"135","author":"Agarwal","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamadermatol.2023.2787","article-title":"Mental health and psychosocial quality-of-life burden among patients with vitiligo: findings from the global VALIANT study","volume":"159","author":"Bibeau","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.jid.2025.06.1596_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2025.06.1596_bib8","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200962","article-title":"AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma","volume":"218","author":"Fukuda","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jid.2025.06.1596_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pcmr.12561","article-title":"Repigmentation in vitiligo: position paper of the vitiligo Global Issues Consensus Conference","volume":"30","author":"Gan","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.06.1596_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd8995","article-title":"scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function","volume":"13","author":"Gellatly","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2025.06.1596_bib11","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/1346-8138.14879","article-title":"Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo","volume":"46","author":"Hayashi","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib13","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib14","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.187.10.1565","article-title":"Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor","volume":"187","author":"Kunisada","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jid.2025.06.1596_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jid.2023.08.006","article-title":"ISG15-USP18 dysregulation by oxidative stress promotes IFN-\u03b3 secretion from CD8+ T cells in vitiligo","volume":"144","author":"Lee","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1523-1747.ep12524353","article-title":"A mouse model for vitiligo","volume":"87","author":"Lerner","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib17","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.1103271","article-title":"A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice","volume":"189","author":"Mehrotra","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.06.1596_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/416854a","article-title":"Dominant role of the niche in melanocyte stem-cell fate determination","volume":"416","author":"Nishimura","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jid.2025.06.1596_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2024.01.002","article-title":"Resident memory T cell contributes to the phenotype of inflammatory vitiligo","volume":"113","author":"Okamura","year":"2024","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.06.1596_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Overwijk","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jid.2025.06.1596_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2025.06.1596_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jid.2018.10.032","article-title":"Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo","volume":"139","author":"Richmond","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.06.1596_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2025.06.1596_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/pcmr.12935","article-title":"Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy","volume":"34","author":"Riding","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.06.1596_bib29","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1002\/cpim.63","article-title":"Mouse model for human vitiligo","volume":"124","author":"Riding","year":"2019","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jid.2025.06.1596_bib25","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two Phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.06.1596_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pcmr.12949","article-title":"An update on vitiligo pathogenesis","volume":"34","author":"Seneschal","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.06.1596_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110171","article-title":"From mice to men: an assessment of preclinical model systems for the study of vitiligo","volume":"262","author":"Wu","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2025.06.1596_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/exd.12184","article-title":"A mouse model of vitiligo induced by monobenzone","volume":"22","author":"Zhu","year":"2013","journal-title":"Exp Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25022754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25022754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:54:13Z","timestamp":1772798053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25022754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022202X25022754"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.06.1596","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.06.1596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}